Literature DB >> 8899105

Regulatory cytokines in inflammatory bowel disease.

F Pallone1, G Monteleone.   

Abstract

Several immunological alterations have been described in inflammatory bowel disease, but their role in the pathogenesis of tissue damage of these disorders is not fully known. Activated immune cells produce proinflammatory and regulatory cytokines able to mediate immune mechanisms underlying intestinal inflammation in both ulcerative colitis and Crohn's disease. Although there is no evidence for an aberrant cytokine secretion in the intestinal mucosa of patients with inflammatory bowel disease, observations seem to indicate that locally released cytokines trigger the preferential differentiation of mucosal lymphocytes into TH1 or TH2 subsets. The unresponsiveness of intestinal mononuclear cells to the inhibiting effects of regulatory cytokines may, also, contribute to this differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899105     DOI: 10.1046/j.1365-2036.1996.22164024.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  3 in total

Review 1.  A lay doctor's guide to the inflammatory process in the gastrointestinal tract.

Authors:  S Pathmakanthan; C J Hawkey
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 2.  Do we really understand what the immunological disturbances in inflammatory bowel disease mean?

Authors:  Epameinondas V Tsianos; Konstantinos Katsanos
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

3.  Interleukin 12 and Th1 responses in inflammatory bowel disease.

Authors:  F Pallone; G Monteleone
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.